Skip to main content
Journal of Global Health logoLink to Journal of Global Health
. 2011 Jun;1(1):87–95.

Efficacy and effectiveness of 20 child health interventions in China: Systematic review of Chinese literature

Jian Shayne F Zhang 1
PMCID: PMC3484750  PMID: 23198106

Abstract

Aim

The research production of the Chinese academics for the past few decades, which is being published in more than nine thousands of Chinese academic periodicals, has recently been digitalized and made available in the public domain. The aim of this study was to systematically identify and assess the evidence from Chinese literature sources on the efficacy and effectiveness of child health interventions in China.

Methods

The Chinese National Knowledge Infrastructure databases were searched for the studies with primary data on efficacy or effectiveness of child health interventions in China between 1980 and 2011. The searches of PubMed and the ‘Lives Saved Tool (LiST)’ evidence base were also performed to identify the counterpart evidence in the English language.

Results

Of 32 interventions initially identified in the Chinese literature, 20 interventions sustained the primary information addressing efficacy or effectiveness. Among preventive interventions (14 interventions), most studies were dedicated to complementary feeding (7 studies), kangaroo mother care (7 studies) and syphilis detection and treatment (4 studies). Among treatment interventions (6 interventions), the most frequently studied were zinc for treatment of diarrhoea (11 studies) and newborn resuscitation (9 studies). The evidence on efficacy or effectiveness of the 32 interventions conducted in Chinese children in the Chinese literature was either of comparable quality, or more informative than the available reports on China in the English literature, which rarely contained studies on child health intervention effectiveness exclusively in Chinese population. The included studies reported positive results unanimously, implying a likely publication bias.

Discussion

The evidence on the efficacy and effectiveness of child health interventions in China is typically modest in quantity and quality, and implies a notable urban-rural discrepancy in applied health systems research to improve child health interventions and programmes. However, it is clear that considerable research interests and initiatives from both inside and outside the country have been concentrating on implementation, long-term operation, evaluation and further development of child health interventions, especially preventive interventions in China.


In 2000, the UN defined a set of goals on which a global political consensus was reached – the ‘Millennium Development Goals’ (1,2). The fourth goal was defined as an ambition to decrease the levels of global child mortality between 1990 and 2015 by two thirds (3). The leading strategies for achieving child mortality reduction were to implement cost-effective interventions in the largest part of the population in low and middle income countries (4-7). These interventions were developed to prevent and treat the leading causes of child mortality, eg, preterm birth complications, birth asphyxia, neonatal infections, pneumonia, congenital abnormalities, diarrhoea, tetanus and HIV/AIDS (5,6). Clearly, there are many possible interventions available, and prioritization of those interventions for implementation among children has become one of the most important health policy goals for the governments, especially in low and middle income countries (8). They are calling for better evidence on the efficacy, effectiveness and cost-effectiveness of each intervention, and also better information on the patterns of child mortality burden in their countries (8). Therefore, understanding the causes of child mortality and the effectiveness of the preventive and treatment interventions has become one of the main interests of the global health community. The ‘Child Survival Series’ published by The Lancet is the earliest and one of the best examples (5,9-12).

The controversy over the true value of many child health interventions still rekindle debates now and then. First, once a few published randomized controlled trials show effectiveness of an intervention, it becomes unethical to scale up the evaluation only to deprive the control arm of apparent benefits. Second, the diversity of study settings and contexts produces enormous confounding and distorts generalization. Third, due to resource constraints, not every study can achieve sufficiently large simple size. Many of them eventually become underpowered, which leads to diverse and often conflicting results. Furthermore, mortality is rarely – if ever – an acceptable outcome of an intervention trial, and the introduction of proxy indicators creates uncertainty over the true effects on mortality and causes ambiguous conclusions. The most recent effort to integrate estimated effectiveness of interventions on child mortality has been published in 2 supplements of the International Journal of Epidemiology and BMC Public Health, providing the theoretical and methodological background information for the ‘Lives Saved Tool (LiST)’ (13). LiST is an evidence-based software module that allows prediction of the impact of scaling up different child health interventions at the national, regional and global level. Although this project is designed and performed to produce reasonably conservative estimates, the primary information gap is still an open issue and that new evidence from any proper sources would further refine the estimates.

One of the potential sources of this kind is academic literature in the Chinese language. The research production of Chinese academics for the past few decades, which is being published in more than nine thousands of Chinese academic periodicals, has recently been digitalized and made available in the public domain. It has been proven that strategically retrieving and analysing qualified publications in the Chinese literature contributes significant evidence and updates to the understanding and knowledge on various topics in the field of child health epidemiology (14). The aim of this study was to systematically identify and assess the evidence from Chinese literature sources on the efficacy and effectiveness of child health interventions in China.

METHODS

The China National Knowledge Infrastructure (CNKI) databases were searched for the period January 1980 to March 2011. CNKI is the most complete source of academic information in China and represents the Chinese equivalent of PubMed or the Web of Knowledge (15). A systematic search of CNKI was performed to identify clinical and community-based studies with primary data reporting either efficacy or effectiveness of child health interventions relevant to neonates, infants, pre-school children or parents in China. Studies were included if: the total cohort was more than 50 subjects; the study design was prospective; the sample population was exclusively Chinese who lived in China at long-term residency base (16,17).

The search terms used were various combinations from a set of terms for ‘efficacy’ and ‘effectiveness’ in their Chinese equivalences, ie, ‘效果’, ‘评价’, ‘影响’, etc. and a set of terms for each intervention in their Chinese equivalences as well, eg, ‘叶酸’, ‘维生素B’, ‘补充’, etc. for ‘folic acid (vitamin B) supplementation’. The first step was to search prevention and treatment interventions targeting causes of child death in general (early development- related excluded). As this search strategy aimed to be as inclusive as possible, it resulted in 6476 publications which mentioned 32 interventions (Table 1). The first level screening based on titles left 649 studies for further identification as the majority were not relevant at all to the topic of ‘efficacy’ or ‘effectiveness’. The abstract screening then left 136 relevant records for full text retrieving. Eventually, 59 studies (up to 1% of the initial screen) for 20 interventions were retained (Table 2). The most common reasons for exclusion were: 1. the total sample cohort was less than 50 subjects, considering that the small sample size might lead to large errors; 2. study design was retrospective, which might cause massive recall bias; 3. the study method was not sufficiently described to understand or interpret the results.

Table 1.

List of 32 interventions chosen for the review*

Preventive interventions
• Antenatal steroids to prevent preterm birth
• Antibiotics for premature rupture of membranes
• Breastfeeding (exclusively for 6 mo)
• Calcium supplementation to prevent pre-eclampsia and eclampsia
• Clean delivery practices
• Complementary feeding
• Detection and management of breech births (Caesarean section)
• Folic acid (vitamin B) supplementation
• Hib vaccination to prevent pneumonia
• Insecticide-treated materials
• Intermittent presumptive treatment for malaria in pregnancy
• Kangaroo mother care
• Labour surveillance (including partograph) for early diagnosis of complications
• Measles vaccination
• Nevirapine and replacement feeding (where possible) to prevent HIV transmission
• Newborn temperature management
• Prevention and management of hypothermia
• Syphilis detection and treatment
• Tetanus toxoid (neonatal)
• Vitamin A supplementation
• Water, sanitation, hygiene
• Zinc supplementation
Treatment interventions
• Antibiotics for dysentery
• Antibiotics for neonatal sepsis
• Anti-malarials
• Community-based pneumonia case management, including antibiotics
• Corticosteroids for preterm labour
• Detection and treatment of asymptomatic bacteriuria
• Newborn resuscitation
• Oral rehydration therapy
• Vitamin A
• Zinc for treatment of diarrhoea

*The interventions were chosen based on Lancet’s Child Survival Series list of interventions (5) and supplemented with any additional interventions on which at least 1 publication in Chinese literature could be found during the period 1980–2011.

Table 2.

The list of 59 retained studies for 20 interventions

Preventive interventions Key search terms General search terms Crude hits Title hits Abstract hits Final hits
Antibiotics for premature rupture of membranes
抗生素;胎膜早破
效果;评价;影响;作用; 干预
309
26
2
1
Clean delivery practices
科学接生
效果;评价;影响;作用; 干预
30
16
4
1
Complementary feeding
辅食添加; 辅食喂养
效果;评价;影响;作用; 干预
147
23
13
7
Folic acid (vitamin B) supplementation
叶酸;维生素B;补充
效果;评价;影响;作用; 干预
123
21
12
2
HiB vaccination to prevent pneumonia
Hib疫苗
效果;评价;影响;作用; 干预
124
34
2
1
Kangaroo mother care
袋鼠式护理;皮肤接触护理
效果;评价;影响;作用; 干预
60
31
15
7
Labour surveillance (including partograph) for early diagnosis of complications
产前检查; 并发症;早期诊断
效果;评价;影响;作用; 干预
366
27
6
2
Measles vaccination
麻疹疫苗
效果;评价;影响;作用; 干预
68
21
5
2
Nevirapine and replacement feeding (where possible) to prevent HIV transmission
奈韦拉平;替代喂?; 艾滋病
效果;评价;影响;作用; 干预
156
44
2
1
Newborn temperature management
新生儿; 温度管理
效果;评价;影响;作用; 干预
1
1
1
1
Syphilis detection and treatment
梅毒
效果;评价;影响;作用; 干预
184
12
10
4
Tetanus toxoid (neonatal)
破伤风;类毒素;新生儿
效果;评价;影响;作用; 干预
197
9
3
2
Vitamin A supplementation
维生素A;维他命A
效果;评价;影响;作用; 干预
558
56
10
2
Water, sanitation, hygiene 水与环境卫生(WES)项目 效果;评价;影响;作用; 干预 19 8 2 1
Treatment interventions
Antibiotics for dysentery
痢疾;抗生素
效果;评价;影响;作用; 干预
263
5
1
1
Corticosteroids for preterm labour
糖皮质激素; 早产
效果;评价;影响;作用; 干预
231
12
6
1
Newborn resuscitation
新生儿复苏
效果;评价;影响;作用; 干预
969
29
18
11
Oral rehydration therapy
口服补液疗法
效果;评价;影响;作用; 干预
112
15
1
1
Vitamin A
维生素A;维他命A
效果;评价;影响;作用; 干预
138
28
2
2
Zinc for treatment of diarrhoea 锌;腹泻;治疗 效果;评价;影响;作用; 干预 170 39 12 11

RESULTS

The distribution of the 59 included studies clustered mainly in the eastern and central regions of China (Figure 1). The latest classification of Chinese regions based on regional macro-economy development recommended dividing China into the eastern, central and western regions. Of the three macro-regions, Western China suffered the most from economical disadvantages. This also provides insight into a further discrepancy: the retained studies conducted in Eastern and Central China were generally led by major university-affiliated hospitals, which were in control of the key resources, such as the provincially leading research and teaching hubs and/or networks. In Western China, however, the retained studies were mostly conducted through cooperation with international organizations, as the overseas aid programmes. Also, an analysis of the period 1980 to 2011, which separated the included studies into 4-year time-periods by frequency, showed the time trend of a steady increase until the period 2004–2007. This was followed by a sharp drop during the period 2008–2011, to the level of activity observed back in 1992–1995 (Figure 2).

Figure 1.

Figure 1

Geographical distribution of 59 retained studies during 1980–2011.

Figure 2.

Figure 2

The time trend of 59 retained studies during 1980–2011.

All the included studies that evaluated a total of 20 interventions were focused on addressing efficacy or effectiveness as the primary outcome. Among preventive interventions (14 interventions), most studies were dedicated to complementary feeding (7 studies), kangaroo mother care (7 studies) and syphilis detection and treatment (4 studies) (Table 3). Among treatment interventions (6 interventions), the most frequently studied were zinc for treatment of diarrhoea (11 studies) and newborn resuscitation (9 studies) (Table 4). Within each intervention, the results from individual studies generally supported each other, providing evidence on the positive effects for all interventions. However, several peculiarities need to be noted: for complementary feeding, each study adopted different food formulas and this may be due to the widespread geographic distribution. For Kangaroo mother care, the research interests varied dramatically, which made the targeting outcomes very diverse – including body temperature management, pain management, weigh gain, physiological and behavioural factors, etc. For syphilis detection and treatment, it was notable that one community-based study conducted in Guangdong province and recruiting 186 517 subjects reported an impressive 61.90% reduction rate during a period of two years. For zinc for treatment of diarrhoea, although OER and anti-diarrhoea duration were common indicators, the ingredients and portions of zinc formula adopted in each study were not consistent. Finally, for newborn resuscitation the universal outcome indicators employed in each study were Apgar-5 and Apgar-10, while Apgar-1 and Apgar-7 occasionally reported with other specific outcomes such as mortality, morbidity of asphyxia, pneumonia and infections.

Table 3.

Three most investigated preventive child health interventions in Chinese literature

Study No
Year
Province
Cohort site
Cohort No.
Sample size (Intervention1)
Sample size (Intervention2)
Sample size (Controls)
Outcome
Indicators of the outcome
1
2
3
4
• Kangaroo mother care
1
2009
Zhejiang
Hospital

100

100
Body temperature management
Temperature recovery speed (hr):
I = 1.665 ± 1.36, C = 6.635 ± 3.838, P < 0.05



2
2008–2009
Guangdong
Hospital

50

50
Venepuncture pain management
Heart rates (/min): I<C, (8-14), P < 0.05
Blood oxygen rate (%): I<C, (1-5), P < 0.05


3
2007
Hebei
Hospital

80

80
Body temperature management
Temperature recovery speed: I = 38(<4h), C = 18(<4h), P < 0.05



4
2007–2008
Guangdong
Hospital

30

30
Weight gain
Weight gain in the 28th day: I = 835g, C = 750g, P < 0.0005



5
2006–2008
Hunan
Hospital

60

60
Physiological and behaviour indicators
Heart rates (/min): I = 142.4 ± 19.1, C = 157.1 ± 24.8, P < 0.01
Blood oxygen rate (%): I = 91.7 ± 4.6, C = 87.9 ± 9.1, P < 0.01


6
2004–2009
Shanxi
Hospital

55

53
Pain management
Heart rates (/min): I = 152.77 ± 15.98, C = 162.34 ± 22.02, P < 0.05
Blood oxygen rate (%): I = 94.03 ± 10.89, C = 93.08 ± 10.62, P < 0.05


7 1999–2002 Guangdong Hospital 54 50 Prognosis of very LBW MDI: I = 99 ± 12, C = 89 ± 10, P < 0.01 PDI:, I = 91 ± 10 C = 83 ± 11, P < 0.05
• Complementary feeding
1
2007–2008
Guangxi
Community

100

100

Percentage-Nutrition (P0-P100): I>C, P < 0.05



2
2006–2008
Jiangsu
Hospital

206

175

Hb (g/L): I = 80.74 ± 13.24 C = 66.43 ± 12.57, P < 0.05
IDA: I = 9(4.5%) C = 33(19.4), P < 0.05


3
2004
Gansu
Community

1000
500
127

DQ: I>C, P < 0.0001



4
2003
Guangdong
Hospital

251

237

Malnutrition: I = 9, C = 42, P < 0.01



5
2002
Jiangsu
Hospital

52

52

Anaemia(%): I = 17.31, C = 38.46, P < 0.05



6
1997
Liaoning
Hospital

107

34

Standard BW: I = 64(87.7), C = 21(61.8), P < 0.01



7 1994 Sichuan Hospital 45 60 58 BW, Height, HC: I>C, P < 0.05
• Syphilis detection and treatment
1
2006–2009
Inner Mongolia
Hospital

168

32

Syphilis(+): 72 children born to Interventions; 19 children born to Controls



2
2005
Guangdong
Community
159017




125(syphilis child cases in theory for 2005) – 4 (syphilis child cases in 2005)



3
2001–2005
Guangdong
Hospital

50

13

Syphilis(+): 8 children born to Interventions; 10 children born to Controls



4 2001–2002 Guangdong Community 186517 Reduction: 61.90%

I – interventions, C – controls, LBW – low birth weight, MDI – mental developmental index, PDI – psychomotor developmental index, Hb – hemoglobin concentration, IDA – iron deficiency anaemia, DQ – developmental quotient, BW – birth weight, HC – head circumference

Table 4.

Two most investigated treatment child health interventions in Chinese literature

Study No
Year
Province
Cohort site
Cohort No.
Sample size (Intervention1)
Sample size (Intervention2)
Sample size (Controls)
Outcome
Indicators of the outcome
1
2
3
4
• Zinc for treatment of diarrhoea
1
2009
Shandong
Hospital

65

60

OER (%): I = 96.92, C = 78.33, P < 0.05
Anti-diarrhoea duration (days): I = 6 ± 1.05, C = 7 ± 1.02, P < 0.05


2
2008–2009
Jiangxi
Hospital

90

90

OER (%): I = 90.0, C = 60.0, P < 0.05
Anti-diarrhoea duration (days): I = 3.11 ± 2.41, C = 5.32 ± 2.11, P < 0.01


3
2008–2009
Tianjing
Hospital

45

42

OER (%): I = 86.3, C = 76.2, P < 0.05



4
2008–2009
Liaoning
Hospital

55

55

OER (%): I = 89.09, C = 65.45, P < 0.01



5
2007–2009
Shaanxi
Hospital

40

40

OER (%): I = 92.5, C = 80.0, P < 0.05
Anti-diarrhoea duration (days): I = 2.81 ± 0.83, C = 4.21 ± 1.98, P < 0.01


6
2007–2009
Sichuan
Hospital

120

120

OER (%): I = 93.4, C = 82.5, P < 0.05



7
2007–2009
Jiangxi
Hospital

60

60

OER (%): I = 93.4, C = 73.2, P < 0.01
Anti-diarrhoea duration (hrs): I = 48.92 ± 3.02, C = 100.23 ± 3.16, P < 0.05


8
2007
Hubei
Hospital

55

50

Anti-diarrhoea duration (hrs): I = 43 ± 6, C = 49 ± 5, P < 0.01



9
2006–2008
Chongqing Hospital

164

168

OER (%): I = 92.07, C = 74.41, P < 0.01
Anti-diarrhoea duration (days): I = 3.11 ± 1.41, C = 4.07 ± 2.12, P < 0.01


10
2005–2007
Sichuan
Hospital

95

91

OER (%): I>CP; <0.01



11 2005–2006 Shandong Hospital 124 126 OER (%): I = 98, C = 92, P < 0.05
• Newborn resuscitation
1
2003–2006
Shandong
Hospital

3050

2850

Asphyxia (%): I = 0.4, C = 2.1, P < 0.01



2
2002–2005
Qinghai
Hospital

682

1318

Mortality (%): I = 15, C = 38, P < 0.05



3
2001–2006
Hubei
Hospital

13905

7808

Asphyxia (%): I = 0.48, C = 2.7, P < 0.01



4
2000–2003
Henan
Hospital

168

55

Apgar-5: I = 8.0 ± 1.0, C = 6.3 ± 0.8, P < 0.01
Apgar-10: I = 9.0 ± 1.1, C = 8.0 ± 0.5, P < 0.01


5
1999
Anhui
Hospital

143

143

Apgar-7: I = 3.4, C = 12.5, P < 0.05
Pneumonia (%): I = 1.3, C = 6.9, P < 0.05
Infections (%): I = 1.3, C = 6.2, P < 0.05

6
1997–2000
Sichuan
Hospital

52

56

Pneumonia: I = 9, C = 2, P < 0.05
HIE: I = 9, C = 1, P < 0.05
Apgar-5: I = 46, C = 50, P < 0.05
Apgar-10: I = 50,C = 52 P < 0.05
7
1997–1998
Jilin
Hospital

2478

782

Asphyxia (%): I = 5.29, C = 15.22, P < 0.01



8
1993–1997
Shandong
Hospital

54

63

Survival rate (%): I = 100, C = 90.47, P < 0.005



9 1989, 1997 Shaanxi Hospital 1349 2414 Asphyxia (%): I = 2.3, C = 4.4, P < 0.05 Apgar-1: I = 6.1, C = 3.7, P < 0.01 Apgar-5: I = 9.7, C = 7.7, P < 0.01

I – interventions, C – controls, OER – overall effect rate, HIE – hypoxic ischemic encephalopathy

The evidence on efficacy or effectiveness of the 32 interventions conducted in Chinese children in the Chinese literature was either of comparable quality, or more informative than the available reports on China in the English literature (Table 5). Although the selected English literature sources showed a substantial and strikingly increasing number of publications on child health interventions during the same period, studies on intervention effectiveness exclusively in Chinese children were very rarely published, and the few rare studies were unlikely to scale-up a systematic analysis or meta-analysis for any of the 32 selected interventions in this paper.

Table 5.

The remaining 15 child health interventions with addressed effectiveness in Chinese literature

PREVENTIVE INTERVENTIONS
Study No.
Year
Province
Cohort
Cohort Size
Sample size (Intervention 1)
Sample size (Intervention 2)
Sample size (Intervention 3)
Sample size (Control)
Outcome
Indicators of outcome
1
2
3
4
• Folic acid (vitamin B) supplementation
1
1996-1997
Zhejiang
Hospital

2265


2265
Congenital heart diseases
RR = 1.77(95%CI: 1.082–2.466); AR = 1.29%
ARP = 43.63%
P < 0.01



2 1993–1995 National Community 130142 117689 NTD 120(NTDs)/130142
137(NTDs)/117689
P < 0.01
• Tetanus toxoid (neonatal)
1
1991–1993
Hunan
Community

170


170(self)

IU/ml(mothers) increased = 0.137–0.008
IU/ml(children) = 0.054
P < 0.01



2 1986–1987 Ningxia Community 67 41 IU/ml >0.01: 89.55% of children born to Interventions; 14.63% of children born to Controls
P < 0.01
• Antibiotics for premature rupture of membranes
1 1992–1997 Henan Hospital 30 30 BW: I = 2580g;
C = 2391g
P < 0.01 1 min Apgar ≤7:
I = 4; C = 9
P < 0.01 Infections:
I = 5; C = 7, P < 0.01
Intracranial
haemorrhage:
I = 5; C = 5
P < 0.01 Death:
I = 0; C = 2
P < 0.01
• Labour surveillance (including partograph) for early diagnosis of complications
1
2006–2008
Zhejiang
Hospital

11186


1066

RDS: I = 290;
C = 52
P < 0.01
LBW: I = 551; C = 88
P < 0.01
Preterm birth:I = 554; C = 95
P < 0.01
Caesarean section rate: I = 68; C = 113
P < 0.01
2 2006–2007 Shandong Hospital 226 208
• Clean delivery practices
1 1991–1993 Heilongjiang Hospital 355 366 Death (Children): I = 9; C = 5
P < 0.01
• Newborn temperature management
1 2002–2003 Gansu Hospital 715 1096 neonatal sclerodema: I = 3 C = 10
P < 0.01
• Hib vaccination to prevent pneumonia
1 2006 Shanghai Community 372 - - 305 Hib+ (%): I = 9.8; C = 3.8
P < 0.01
• Water, sanitation, hygiene
1 1996–2000 Gansu Community 21 villages Sanitation per household, population educated, children hygiene behaviour positive change rate are all increased
• Vitamin A supplementation
1
2001–2005
Chongqing
Institute

64


61

Hb (g/L): I = 122.0 ± 7.5; C = 120.3 ± 7.87
P < 0.001



2 1991–1992 Hebei Community 327 343 Z value:I>C
P < 0.01
• Nevirapine and replacement feeding (where possible) to prevent HIV transmission
1 2005 Yunnan Community 61 61 - - - Reduction: 7.0%
• Measles vaccination
1
2000–2007
Guizhou
Community
25302





Morbidity: 26.68/100000(2002)
3.52/100000(2003)
0.20/100000(2007)



2 1991 Hubei Community 503 Reduction in 6 y: 59.22%
TREATMENT INTERVENTIONS
Study No.
Year
Province
Cohort
Cohort Size
Sample size (Intervention 1)
Sample size (Intervention 2)
Sample size (Intervention 3)
Sample size (Control)
Outcome
Indicators of outcome
1
2
3
4
• Corticosteroids for preterm labour
1 2000 Anhui Hospital 18 19 5 Hyaline membrane disease (<34 weeks gestation): I<C
P < 0.001
• Oral rehydration therapy
1 2001–2005 Heilongjiang Hospital 60 60 Temperature recovery speed (days): I = 1.51 ± 0.89;C = 3.87 ± 2.03
P < 0.01 Diarrhoea recovery speed (days): I = 2.97 ± 1.45;C = 5.72 ± 2.43
P < 0.01 General recovery speed (days): I = 4.70 ± 1.98;C = 7.28 ± 2.86
P < 0.01
• Antibiotics for dysentery
1 1994–1996 Jiangsu Hospital 24 30 23 2 preferred based on temperature recovery speed and anti–diarrhoea duration: Both Ps <0.01
• Vitamin A
1
2003–2006
Jiangxi
Hospital

42


35
Recurrent respiratory infections
Temperature recovery speed (days): I = 3.5; C = 6.0
P < 0.01
Diarrhoea recovery duration (days): I = 5; C = 8
P < 0.01
Diarrhoea recovery duration (days): I = 5; C = 8
P < 0.01
Recurrence (%): Interventions<Controls
P < 0.05
2 1990–2000 Chongqing Hospital 30 30 Measles VA (µmol/L): I = 1.17 ± 0.12; C = 0.84 ± 0.24
P < 0.01 Cough recovery duration (days): I = 8.12 ± 1.24: C = 9.36 ± 1.68
P < 0.01 Diarrhoea recovery duration (days): I = 7.88 ± 1.87; C = 9.13 ± 1.20
P < 0.01 Complications (%) Interventions<Controls
Ps <0.05

I – intervention, C – control, RR – risk ratio, AR – attribute ratio, ARP – attribute ratio percentage, RDS – respiratory distress syndrome, Hb – hemoglobin concentration

DISCUSSION

This paper represents the very first attempt to systematically investigate the accessibility, quantity and quality of the research production of Chinese academics over the period of the past 30 years on efficacy and effectiveness of child health interventions in China. It is possible that a parallel review and/or the extended systematic review of other digital Chinese-language databases such as Chongqing VIP and Wanfang would have identified slightly more studies. However, the initial searching within the two additional databases did not seem to add any further evidence (my search on February 15, 2011), and this might due to the extremely massive overlap in indexed journals of the three domains (15,18,19). It is very unlikely that substantial omissions could have drawn dramatically different conclusions on quantity assessment from those that this paper offers.

Conducting studies which evaluate interventions generally not only requires substantial financial support and high-level technical expertise, but it is also subject to various vital factors, such as ethical approval, unique local conditions/customs and liaisons with multiple organizations, to name a few. Usually, a single team of researchers has to invest tremendous efforts to ensure smooth workflow for years to achieve the ultimate outcome, either positive or negative, even possessing sufficient essential resources. This may explain why, in the global context, the research production on intervention evaluation is relatively scarce and the relevant studies with large sample sizes and robust study designs are extremely valuable.

According to GRADE criteria, the retained studies in the Chinese literature are generally of modest quality (17). Relatively small sample sizes and wide confidence intervals make it unjustified that all retained studies should be expected to show positive effects of the investigated interventions, implying a likely publication bias. This has not ridden the Chinese literature only, as there is a traditional academic and industrial resistance to reporting and pursuing publication of negative effects, especially where the previous evaluation showed benefits. China may consider incorporating the existing national ethics approval system with a mandatory national trail registration system in order to keep all the trails conducted in China well tracked and ensure that the final outcomes are reported and made public.

Despite insufficient information to fully assess the current situation of child health interventions in depth in China, the urban-rural discrepancy in study distribution and funding resources is particularly notable. While the studies in Eastern and Central China were conducted by regional leading institutes as scientific research projects, Western China, the most remote and mountainous region of the country, seems to still be reliant on overseas aid to implement child health interventions. The longstanding urban-rural socio-economical imbalance results in limited academic and industrial activities focusing on the most underdeveloped region of China, where implementing, evaluating and further developing appropriately customized interventions may achieve highest potential impact on child mortality reduction and other aspects of child health in China as a whole.

Comprehensive and accurate data and evidence on child health interventions are indispensable for prioritizing prevention and treatment strategies in order to achieve optimal policy decisions. It is clear that considerable research interests and initiatives from both inside and outside the country have been concentrating on child health interventions, especially preventive interventions in China. How to best harness and facilitate those potential strengths in this still new and fast growing field could be the next opportunity and challenge that the country has to take.

Acknowledgments

Funding: This study was supported by the Bill and Melinda Gates Foundation Grant to the U.S. Fund for UNICEF.

Ethical approval: Not required.

Authorship declaration: JSFZ conceived and performed the study, analyzed and interpreted the results and wrote the article.

Competing interests: The author has completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.

References

  • 1.The International Bank for Reconstruction and Development, The World Bank. Global monitoring report 2006 Millennium Development Goals: Strengthening mutual accountability, aid, trade, and governance. Washington, DC: The World Bank. 2006. [Google Scholar]
  • 2.UNDP. About the MDGs: Basics. Available at: http://www.undp.org/mdg/basics.shtml Accessed: 22 February 2011.
  • 3.UNICEF. Countdown to 2015: Tracking progress in maternal, newborn and child survival: the 2008 report. 2008. Available at: www.countdown2015mnch.org/documents/2008report/2008Countdown2015FullReport_2ndEdition_1x1.pdf Accessed: 22 February 2011.
  • 4.Bryce J, Black RE, Walker N, Bhutta ZA, Lawn JE, Steketee RW. Can the world afford to save the lives of 6 million children each year? Lancet. 2005;365:2193–2200. doi: 10.1016/S0140-6736(05)66777-3. [DOI] [PubMed] [Google Scholar]
  • 5.Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS, Bellagio Child Survival Study Group How many child deaths can we prevent this year? Lancet. 2003;362:65–71. doi: 10.1016/S0140-6736(03)13811-1. [DOI] [PubMed] [Google Scholar]
  • 6.Bryce J, Terreri N, Victora CG, Mason E, Daelmans B, Bhutta ZA, et al. Countdown to 2015: tracking intervention coverage for child survival. Lancet. 2006;368:1067–1076. doi: 10.1016/S0140-6736(06)69339-2. [DOI] [PubMed] [Google Scholar]
  • 7.Lawn JE. A price tag for newborn and child survival. Available at: http://cs.server2.textor.com/alldocs/40%20 Joy%20Lawn.ppt Accessed: 22 February 2011.
  • 8.Rudan I, Kapiriri L, Tomlinson M, Balliet M, Cohen B, Chopra M. Evidence-based priority setting for health care and research: Tools to support policy in maternal, neonatal, and child health in Africa. PLoS Med. 2010;7:e1000308. doi: 10.1371/journal.pmed.1000308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet. 2003;361:2226–2234. doi: 10.1016/S0140-6736(03)13779-8. [DOI] [PubMed] [Google Scholar]
  • 10.Bryce J, el Arifeen S, Pariyo G, Lanata C, Gwatkin D, Habicht JP, Multi-Country Evaluation of IMCI Study Group Reducing child mortality: can public health deliver? Lancet. 2003;362:159–164. doi: 10.1016/S0140-6736(03)13870-6. [DOI] [PubMed] [Google Scholar]
  • 11.Victora CG, Wagstaff A, Schellenberg JA, Gwatkin D, Claeson M, Habicht JP. Applying an equity lens to child health and mortality: more of the same is not enough. Lancet. 2003;362:233–241. doi: 10.1016/S0140-6736(03)13917-7. [DOI] [PubMed] [Google Scholar]
  • 12.Claeson M, Gillespie D, Mshinda H, Troedsson H, Victora CG, Bellagio Study Group on Child Survival Knowledge into action for child survival. Lancet. 2003;362:323–327. doi: 10.1016/S0140-6736(03)13977-3. [DOI] [PubMed] [Google Scholar]
  • 13.LiST: The Lives Saved Tool. Available at: http://www.jhsph.edu/dept/ih/IIP/list Accessed: 22 February 2011.
  • 14.Rudan I, Chan KY, Zhang JSF, Theodoratou E, Feng XL, Salomon J, et al. Causes of deaths in children younger than 5 years in China in 2008. Lancet. 2010;375:1083–1089. doi: 10.1016/S0140-6736(10)60060-8. [DOI] [PubMed] [Google Scholar]
  • 15.China National Knowledge Infrastructure. Available at: www.global.cnki.net Accessed: 22 February 2011.
  • 16.Walker N, Fischer-Walker C, Bryce J, Bahl R, Cousens S, CHERG Review Groups on Intervention Effects Standards for CHERG reviews of intervention effects on child survival. Int J Epidemiol. 2010;39(Suppl 1):i21–i31. doi: 10.1093/ije/dyq036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Bossuyt P, Chang S, et al. GRADE: assessing the quality of evidence for diagnostic recommendations. ACP J Club. 2008;149:2. doi: 10.1093/ije/dyq036. [DOI] [PubMed] [Google Scholar]
  • 18.Chongqing VIP database. Available at: http://www.cqvip.com Accessed: 22 February 2011.
  • 19.Wanfangdatabase. Available at: http://www.wanfangdata.com.cn Accessed: 22 February 2011.

Articles from Journal of Global Health are provided here courtesy of International Society for Global Health

RESOURCES